Merrimack Pharmaceuticals, Inc.
NASDAQ: MACK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gary L. Crocker
- Headquarters
- Cambridge, United States
- IPO year
- 2012
- Market cap
- $224.0M
- Website
- https://www.merrimack.com
Loading MACK…
Loading profile data…Frequently asked questions about MACK
What does Merrimack Pharmaceuticals, Inc. (MACK) do?
Founded in 1993, Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts.
Where does MACK trade?
Merrimack Pharmaceuticals, Inc. (MACK) trades on the NASDAQ Global Market.
What sector is MACK in?
Merrimack Pharmaceuticals, Inc. (MACK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Merrimack Pharmaceuticals, Inc.?
Gary L. Crocker is the chief executive officer of Merrimack Pharmaceuticals, Inc. (MACK).
Where is Merrimack Pharmaceuticals, Inc. headquartered?
Merrimack Pharmaceuticals, Inc. is headquartered in United States.
Does MACK pay a dividend?
Yes — Merrimack Pharmaceuticals, Inc. (MACK) paid a trailing twelve-month dividend of USD 15.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did MACK go public?
Merrimack Pharmaceuticals, Inc. (MACK) completed its initial public offering in 2012.